Symbols / SCLX $7.24 +6.00% Scilex Holding Company

Healthcare • Drug Manufacturers - General • United States • NCM
SCLX Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is based in Palo Alto, California.

Fundamentals
Scroll to Statements
Market Cap 50.92M Enterprise Value 168.51M Income -402.49M Sales 30.25M Book/sh -29.75 Cash/sh 1.56
Dividend Yield — Payout 0.00% Employees 34 IPO — P/E — Forward P/E 9.92
PEG — P/S 1.68 P/B -0.24 P/C — EV/EBITDA -0.63 EV/Sales 5.57
Quick Ratio 0.05 Current Ratio 0.08 Debt/Eq — LT Debt/Eq — EPS (ttm) -36.48 EPS next Y 0.73
EPS Growth — Revenue Growth -67.80% Earnings 2026-03-12 ROA -74.33% ROE — ROIC —
Gross Margin 64.96% Oper. Margin -7.82% Profit Margin 0.00% Shs Outstand 7.03M Shs Float 4.71M Short Float 3.39%
Short Ratio 5.78 Short Interest — 52W High 34.27 52W Low 3.92 Beta 1.42 Avg Volume 45.45K
Volume 27.23K Target Price — Recom None Prev Close $6.83 Price $7.24 Change 6.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$7.24
Latest analyst target
3. DCF / Fair value
$62.92
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.24
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-04-11 down D. Boral Capital Buy → Hold —
2025-04-02 main D. Boral Capital Buy → Buy $18
2025-02-28 main D. Boral Capital Buy → Buy $22
2025-01-27 init D. Boral Capital — → Buy $22
2024-10-21 reit HC Wainwright & Co. Buy → Buy $7
2024-10-16 init Alliance Global Partners — → Buy $14
2024-06-17 reit HC Wainwright & Co. Buy → Buy $7
2024-06-13 init Rodman & Renshaw — → Buy $13
2024-06-11 reit HC Wainwright & Co. Buy → Buy $7
2024-05-23 main HC Wainwright & Co. Buy → Buy $7
2024-05-03 main HC Wainwright & Co. Buy → Buy $8
2023-12-04 reit HC Wainwright & Co. Buy → Buy $12
2023-10-13 init B. Riley Securities — → Buy $4
2023-10-09 init HC Wainwright & Co. — → Buy $12
News
RSS: Latest SCLX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-30 SCILEX HOLDING CO Beneficial Owner of more than 10% of a Class of Security — 20,657,300 $12.30 $270,814,177
2024-12-18 SHAH JAISIM Chief Executive Officer — 30,000 $0.46 $13,800
2024-10-31 JI HENRY H Officer and Director — 8,888 $0.94 $8,351
2024-10-29 SHAH JAISIM Chief Executive Officer — 32,000 $0.99 $31,670
2024-10-18 FOLLOWWILL DORMAN Director — 1,000 $0.99 $990
2024-10-18 CHUN JAY Director — 5,000 $0.95 $4,750
2024-10-17 JI HENRY H Officer and Director — 10,000 $0.97 $9,710
2024-10-17 WU YUE ALEXANDER Director — 20,000 $0.95 $18,992
2024-10-17 LEMUS DAVID Director — 2,000 $0.90 $1,800
2024-10-16 SHAH JAISIM Chief Executive Officer — 30,000 $0.99 $29,751
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
30.25
-46.54%
56.59
+21.07%
46.74
+22.90%
38.03
Operating Revenue
30.25
-46.54%
56.59
+21.07%
46.74
+22.90%
38.03
Cost Of Revenue
10.60
-36.49%
16.69
+6.43%
15.68
+45.23%
10.80
Reconciled Cost Of Revenue
10.34
-37.99%
16.67
+6.60%
15.64
+45.39%
10.76
Gross Profit
19.65
-50.74%
39.90
+28.46%
31.06
+14.04%
27.24
Operating Expense
291.96
+120.03%
132.69
-2.79%
136.49
+75.28%
77.87
Research And Development
20.71
+114.81%
9.64
-24.36%
12.75
+40.78%
9.05
Selling General And Administration
266.88
+124.24%
119.02
-0.52%
119.64
+84.36%
64.89
Total Expenses
302.56
+102.55%
149.38
-1.84%
152.17
+71.62%
88.67
Operating Income
-272.30
-193.47%
-92.79
+11.99%
-105.43
-108.22%
-50.63
Total Operating Income As Reported
-346.01
-314.90%
-83.40
+20.90%
-105.43
-108.22%
-50.63
EBITDA
-357.94
-435.85%
-66.80
+38.77%
-109.10
-1013.87%
-9.79
Normalized EBITDA
-233.62
-149.79%
-93.52
+13.78%
-108.47
-132.41%
-46.67
Reconciled Depreciation
4.62
+14.26%
4.05
-2.41%
4.15
+4.67%
3.96
EBIT
-362.57
-411.78%
-70.84
+37.44%
-113.25
-723.28%
-13.76
Total Unusual Items
-124.33
-565.24%
26.72
+4341.90%
-0.63
-101.71%
36.88
Total Unusual Items Excluding Goodwill
-124.33
-565.24%
26.72
+4341.90%
-0.63
-101.71%
36.88
Special Income Charges
-81.05
-963.10%
9.39
0.00
-100.00%
28.63
Other Special Charges
7.70
+181.95%
-9.39
—
-28.63
Impairment Of Capital Assets
73.36
0.00
—
—
Net Income
-358.73
-392.72%
-72.81
+36.32%
-114.33
-389.35%
-23.36
Pretax Income
-374.03
-413.72%
-72.81
+36.31%
-114.32
-389.38%
-23.36
Net Non Operating Interest Income Expense
-11.46
-483.75%
-1.96
-83.80%
-1.07
+88.88%
-9.60
Interest Expense Non Operating
11.46
+483.75%
1.96
+83.80%
1.07
-88.88%
9.60
Net Interest Income
-11.46
-483.75%
-1.96
-83.80%
-1.07
+88.88%
-9.60
Interest Expense
11.46
+483.75%
1.96
+83.80%
1.07
-88.88%
9.60
Interest Income Non Operating
—
—
—
—
Interest Income
—
—
—
—
Other Income Expense
-90.26
-511.38%
21.94
+380.62%
-7.82
-121.20%
36.88
Other Non Operating Income Expenses
-25.35
-430.13%
-4.78
+33.48%
-7.19
—
Gain On Sale Of Security
-43.28
-349.67%
17.33
+2851.27%
-0.63
-107.64%
8.24
Tax Provision
0.03
+2700.00%
-0.00
-107.69%
0.01
+225.00%
0.00
Tax Rate For Calcs
0.00
+1499900.00%
0.00
-99.99%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-26.11
-7113428.53%
0.00
+100.28%
-0.13
-101.71%
7.74
Net Income Including Noncontrolling Interests
-374.05
-413.76%
-72.81
+36.32%
-114.33
-389.35%
-23.36
Net Income From Continuing Operation Net Minority Interest
-358.73
-392.72%
-72.81
+36.32%
-114.33
-389.35%
-23.36
Net Income From Continuing And Discontinued Operation
-358.73
-392.72%
-72.81
+36.32%
-114.33
-389.35%
-23.36
Net Income Continuous Operations
-374.05
-413.76%
-72.81
+36.32%
-114.33
-389.35%
-23.36
Minority Interests
15.32
0.00
—
—
Normalized Income
-260.51
-161.74%
-99.53
+12.56%
-113.83
-116.84%
-52.50
Net Income Common Stockholders
-402.49
-452.81%
-72.81
+56.40%
-166.98
-614.67%
-23.36
Otherunder Preferred Stock Dividend
43.75
0.00
—
0.00
Diluted EPS
-36.48
-353.17%
-8.05
+82.03%
-44.80
-652.94%
-5.95
Basic EPS
-36.48
-403.87%
-7.24
+83.84%
-44.80
-652.94%
-5.95
Basic Average Shares
11.03
+9.67%
10.06
+170.25%
3.72
-2.93%
3.84
Diluted Average Shares
11.03
+8.76%
10.14
+172.51%
3.72
-2.93%
3.84
Diluted NI Availto Com Stockholders
-402.49
-452.81%
-72.81
+56.40%
-166.98
-614.67%
-23.36
Amortization
4.36
+8.26%
4.03
-1.83%
4.11
+4.69%
3.92
Amortization Of Intangibles Income Statement
4.36
+8.26%
4.03
-1.83%
4.11
+4.69%
3.92
Depreciation Amortization Depletion Income Statement
4.36
+8.26%
4.03
-1.83%
4.11
+4.69%
3.92
Depreciation And Amortization In Income Statement
4.36
+8.26%
4.03
-1.83%
4.11
+4.69%
3.92
Earnings From Equity Interest
59.42
0.00
—
—
Preferred Stock Dividends
—
—
52.65
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
364.98
+292.65%
92.95
-8.25%
101.31
Current Assets
38.36
-7.68%
41.55
-11.19%
46.78
Cash Cash Equivalents And Short Term Investments
10.98
+235.61%
3.27
-16.55%
3.92
Cash And Cash Equivalents
4.96
+51.44%
3.27
-16.55%
3.92
Other Short Term Investments
6.03
—
—
Receivables
15.24
-42.35%
26.44
-23.57%
34.60
Accounts Receivable
15.24
-42.35%
26.44
-23.57%
34.60
Inventory
4.79
+96.59%
2.44
-42.19%
4.21
Prepaid Assets
—
—
—
Other Current Assets
7.34
-21.85%
9.40
+132.08%
4.05
Total Non Current Assets
326.62
+535.38%
51.41
-5.73%
54.53
Net PPE
28.42
+868.87%
2.93
-19.97%
3.67
Gross PPE
28.74
+858.89%
3.00
-19.50%
3.72
Accumulated Depreciation
-0.32
-401.56%
-0.06
-10.34%
-0.06
Properties
0.00
0.00
0.00
Land And Improvements
0.86
0.00
—
Machinery Furniture Equipment
8.41
+25372.73%
0.03
-19.51%
0.04
Construction In Progress
0.91
+31.93%
0.69
+0.00%
0.69
Other Properties
14.82
+565.98%
2.23
-24.40%
2.94
Leases
3.75
+7392.00%
0.05
+0.00%
0.05
Goodwill And Other Intangible Assets
137.28
+198.87%
45.93
-8.07%
49.97
Goodwill
13.48
+0.00%
13.48
+0.00%
13.48
Other Intangible Assets
123.80
+281.47%
32.45
-11.05%
36.48
Investments And Advances
128.04
+5190.91%
2.42
0.00
Long Term Equity Investment
127.04
—
—
Other Investments
1.00
-58.68%
2.42
—
Non Current Prepaid Assets
—
—
—
Other Non Current Assets
32.89
+27535.29%
0.12
-86.73%
0.90
Total Liabilities Net Minority Interest
576.73
+101.94%
285.60
+4.14%
274.25
Current Liabilities
483.65
+86.28%
259.63
+3.70%
250.38
Payables And Accrued Expenses
387.71
+76.65%
219.48
+55.99%
140.70
Payables
86.32
+61.35%
53.50
+26.15%
42.41
Accounts Payable
86.27
+63.94%
52.62
+28.49%
40.95
Current Accrued Expenses
301.39
+81.57%
165.99
+68.87%
98.30
Total Tax Payable
0.05
-94.29%
0.88
-39.67%
1.45
Current Debt And Capital Lease Obligation
88.51
+148.70%
35.59
-67.40%
109.19
Current Debt
86.78
+148.82%
34.88
-67.84%
108.43
Other Current Borrowings
83.26
+138.74%
34.88
-67.84%
108.43
Current Capital Lease Obligation
1.73
+142.72%
0.71
-5.93%
0.76
Current Deferred Liabilities
4.17
-8.57%
4.56
+829.12%
0.49
Current Deferred Revenue
3.76
-8.53%
4.12
0.00
Other Current Liabilities
3.26
—
—
Total Non Current Liabilities Net Minority Interest
93.08
+258.55%
25.96
+8.77%
23.87
Long Term Debt And Capital Lease Obligation
35.63
+1404.69%
2.37
-87.71%
19.27
Long Term Debt
22.48
+2560.36%
0.84
-95.04%
17.04
Long Term Capital Lease Obligation
13.15
+763.49%
1.52
-31.92%
2.24
Non Current Deferred Liabilities
6.68
+30.08%
5.13
+77.31%
2.90
Non Current Deferred Revenue
4.64
+72.66%
2.69
0.00
Other Non Current Liabilities
0.17
+11.46%
0.16
-12.29%
0.18
Stockholders Equity
-207.78
-7.86%
-192.64
-11.39%
-172.94
Common Stock Equity
-207.78
-7.86%
-192.64
-11.39%
-172.94
Capital Stock
0.00
0.00
-100.00%
0.02
Common Stock
0.00
0.00
-100.00%
0.02
Preferred Stock
0.00
0.00
0.00
Share Issued
8.49
+22.14%
6.95
+51.99%
4.57
Ordinary Shares Number
7.03
+34.33%
5.24
+83.22%
2.86
Treasury Shares Number
1.46
-15.03%
1.72
+0.00%
1.72
Additional Paid In Capital
796.72
+75.25%
454.61
+11.48%
407.81
Retained Earnings
-921.79
-63.71%
-563.05
-14.85%
-490.25
Gains Losses Not Affecting Retained Earnings
-5.80
-191.86%
6.32
0.00
Treasury Stock
76.92
-15.03%
90.52
+0.00%
90.52
Minority Interest
-3.97
0.00
—
Other Equity Adjustments
-5.80
-191.86%
6.32
—
Total Equity Gross Minority Interest
-211.75
-9.92%
-192.64
-11.39%
-172.94
Total Capitalization
-185.30
+3.39%
-191.80
-23.03%
-155.90
Working Capital
-445.29
-104.18%
-218.09
-7.12%
-203.60
Invested Capital
-98.52
+37.21%
-156.92
-230.56%
-47.47
Total Debt
124.14
+227.05%
37.96
-70.45%
128.46
Net Debt
104.30
+221.44%
32.45
-73.30%
121.55
Capital Lease Obligations
14.88
+565.36%
2.24
-25.33%
3.00
Net Tangible Assets
-345.06
-44.63%
-238.58
-7.03%
-222.90
Tangible Book Value
-345.06
-44.63%
-238.58
-7.03%
-222.90
Current Notes Payable
3.52
0.00
—
Derivative Product Liabilities
50.60
+176.45%
18.30
+1105.73%
1.52
Dueto Related Parties Current
—
—
—
Interest Payable
6.86
0.00
—
Preferred Stock Equity
0.00
+0.00%
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
3.82
-80.28%
19.35
+193.44%
-20.71
+2.59%
-21.26
Cash Flow From Continuing Operating Activities
3.82
-80.28%
19.35
+193.44%
-20.71
+2.59%
-21.26
Net Income From Continuing Operations
-374.05
-413.76%
-72.81
+36.32%
-114.33
-389.35%
-23.36
Depreciation Amortization Depletion
4.62
+14.26%
4.05
-2.41%
4.15
+4.67%
3.96
Depreciation And Amortization
4.62
+14.26%
4.05
-2.41%
4.15
+4.67%
3.96
Other Non Cash Items
188.22
+2806.01%
6.48
-24.40%
8.57
+148.80%
-17.56
Stock Based Compensation
15.49
-1.26%
15.69
+7.49%
14.60
+176.44%
5.28
Provisionand Write Offof Assets
0.00
-100.00%
18.48
0.00
—
Asset Impairment Charge
73.36
0.00
—
—
Operating Gains Losses
-15.10
+13.10%
-17.38
-3494.14%
0.51
+101.45%
-35.25
Gain Loss On Investment Securities
44.31
+355.01%
-17.38
-3494.14%
0.51
+107.74%
-6.61
Unrealized Gain Loss On Investment Securities
-2.69
0.00
—
—
Change In Working Capital
113.97
+75.77%
64.84
-1.46%
65.80
+44.09%
45.67
Change In Receivables
13.84
+320.79%
-6.27
+53.09%
-13.36
-91.75%
-6.97
Changes In Account Receivables
13.84
+320.79%
-6.27
+53.09%
-13.36
-91.75%
-6.97
Change In Inventory
1.80
+23.05%
1.46
+151.52%
-2.84
-339.70%
1.18
Change In Prepaid Assets
3.30
+788.94%
-0.48
-8.62%
-0.44
+83.23%
-2.63
Change In Payables And Accrued Expense
95.87
+35.15%
70.94
-13.79%
82.28
+52.49%
53.96
Change In Accrued Expense
82.75
+30.27%
63.52
+1.79%
62.40
+196.74%
21.03
Change In Payable
13.12
+76.86%
7.42
-62.68%
19.88
-39.63%
32.93
Change In Account Payable
13.12
+76.86%
7.42
-62.68%
19.88
+608.48%
2.81
Change In Other Current Assets
-0.00
+90.00%
-0.03
-103.51%
0.85
+144.29%
0.35
Change In Other Current Liabilities
-0.83
-6.39%
-0.78
-12.52%
-0.69
-203.49%
-0.23
Investing Cash Flow
4.08
+252.67%
-2.67
-710.61%
-0.33
+84.03%
-2.07
Cash Flow From Continuing Investing Activities
4.08
+252.67%
-2.67
-710.61%
-0.33
+84.03%
-2.07
Net PPE Purchase And Sale
-0.13
0.00
+100.00%
-0.03
-328.57%
-0.01
Purchase Of PPE
-0.13
0.00
+100.00%
-0.03
-328.57%
-0.01
Capital Expenditure
-0.73
-22.17%
-0.60
-81.82%
-0.33
+84.03%
-2.07
Net Investment Purchase And Sale
-17.04
-721.06%
-2.08
0.00
—
Purchase Of Investment
-17.04
-721.06%
-2.08
0.00
—
Net Business Purchase And Sale
41.12
0.00
—
—
Purchase Of Business
—
—
—
—
Gain Loss On Sale Of Business
-4.66
0.00
—
—
Net Intangibles Purchase And Sale
-0.60
+0.00%
-0.60
-100.00%
-0.30
+85.44%
-2.06
Purchase Of Intangibles
-0.60
+0.00%
-0.60
-100.00%
-0.30
+85.44%
-2.06
Net Other Investing Changes
-19.27
—
—
—
Financing Cash Flow
-5.46
+69.88%
-18.13
-176.88%
23.58
+11.39%
21.17
Cash Flow From Continuing Financing Activities
-5.46
+69.88%
-18.13
-176.88%
23.58
+11.39%
21.17
Net Issuance Payments Of Debt
0.44
+100.68%
-64.21
-8920.19%
0.73
+102.33%
-31.25
Issuance Of Debt
21.53
-82.13%
120.44
+9.14%
110.35
+52.51%
72.36
Repayment Of Debt
-21.09
+88.58%
-184.65
-68.44%
-109.63
-5.81%
-103.61
Long Term Debt Issuance
21.53
-82.13%
120.44
+9.14%
110.35
+52.51%
72.36
Long Term Debt Payments
-21.09
+88.58%
-184.65
-68.44%
-109.63
-5.81%
-103.61
Net Long Term Debt Issuance
0.44
+100.68%
-64.21
-8920.19%
0.73
+102.33%
-31.25
Short Term Debt Issuance
—
—
24.00
0.00
Short Term Debt Payments
—
—
-84.63
0.00
Net Short Term Debt Issuance
—
—
24.00
0.00
Net Common Stock Issuance
0.00
-100.00%
44.64
+75.34%
25.46
0.00
Common Stock Payments
—
0.00
+100.00%
-10.00
0.00
Repurchase Of Capital Stock
—
0.00
+100.00%
-10.00
0.00
Proceeds From Stock Option Exercised
3.62
+99.56%
1.81
+59.74%
1.14
+1082.29%
0.10
Net Other Financing Charges
-9.52
-2465.23%
-0.37
+90.08%
-3.74
-107.15%
52.33
Changes In Cash
2.44
+267.40%
-1.46
-157.25%
2.54
+218.15%
-2.15
Effect Of Exchange Rate Changes
-0.76
0.00
—
—
Beginning Cash Position
3.27
-30.81%
4.73
+116.53%
2.18
-49.65%
4.34
End Cash Position
4.96
+51.44%
3.27
-30.81%
4.73
+116.53%
2.18
Free Cash Flow
3.08
-83.56%
18.75
+189.12%
-21.04
+9.81%
-23.32
Interest Paid Supplemental Data
0.94
-40.10%
1.56
+9.47%
1.43
0.00
Common Stock Issuance
0.00
-100.00%
44.64
+25.89%
35.46
0.00
Earnings Losses From Equity Investments
-54.76
0.00
—
—
Issuance Of Capital Stock
0.00
-100.00%
44.64
+25.89%
35.46
0.00
Sale Of Business
41.12
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category